<prompt> All of the following statements about Exenatide are true exceptIt is a GLP-1 analogueIt can be used for treatment of type 1 diabetes mellitusIt is given subcutaneouslyIt decreases glucagon  <response>: Refer CMDT 2010 p1095 Exenatide is a GLP-1 receptor agonist that is more resistant to DPP-4 action band cleared by the kidney When this drug bus given to patients with type 2 diabetes by subcutaneous injection twice daily Exenatide appears to have the sane effects as GLP-1 on glucagon suppression and gastric emptying 